tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

EXEL Stock Latest News

Exelixis price target lowered to $43 from $46 at RBC Capital
The FlyExelixis price target lowered to $43 from $46 at RBC Capital
13d ago
MRK
EXEL
Hold Rating on Exelixis Amid Emerging Belzutifan Competition and Uncertain Cabo Revenue Visibility
PremiumRatings
Hold Rating on Exelixis Amid Emerging Belzutifan Competition and Uncertain Cabo Revenue Visibility
13d ago
EXEL
Exelixis: Welireg Competition Tempers RCC Upside but Embedded Cabozantinib Franchise Supports Hold Rating
PremiumRatings
Exelixis: Welireg Competition Tempers RCC Upside but Embedded Cabozantinib Franchise Supports Hold Rating
13d ago
EXEL
Crocs, Linde, Zillow, Exelixis, Qorvo: Insider Cash-Outs
PremiumWeekend Updates
Crocs, Linde, Zillow, Exelixis, Qorvo: Insider Cash-Outs
15d ago
Z
LIN
Exelixis: Solid Financial Beat and Advancing Oncology Pipeline Drive Upgraded Earnings Outlook and $54 Price Target
PremiumRatings
Exelixis: Solid Financial Beat and Advancing Oncology Pipeline Drive Upgraded Earnings Outlook and $54 Price Target
1M ago
EXEL
Exelixis price target raised to $54 from $52 at H.C. Wainwright
PremiumThe FlyExelixis price target raised to $54 from $52 at H.C. Wainwright
1M ago
EXEL
Arcus Biosciences downgraded to Equal Weight from Overweight at Wells Fargo
Premium
The Fly
Arcus Biosciences downgraded to Equal Weight from Overweight at Wells Fargo
1M ago
EXEL
RCUS
Exelixis Earnings Call: CABOMETYX Strength, ZANZA Catalyst
Premium
Company Announcements
Exelixis Earnings Call: CABOMETYX Strength, ZANZA Catalyst
1M ago
EXEL
Exelixis price target raised to $44 from $43 at Stifel
PremiumThe Fly
Exelixis price target raised to $44 from $43 at Stifel
1M ago
EXEL
Exelixis: Solid Q4 Execution and Advancing Pipeline Underpin Buy Rating and 2026 Earnings Power
PremiumRatings
Exelixis: Solid Q4 Execution and Advancing Pipeline Underpin Buy Rating and 2026 Earnings Power
1M ago
EXEL
Exelixis reports Q4 EPS 94c, consensus 81c
PremiumThe Fly
Exelixis reports Q4 EPS 94c, consensus 81c
1M ago
EXEL
Exelixis sees FY26 revenue $2.525B-$2.625B, consensus $2.6B
PremiumThe Fly
Exelixis sees FY26 revenue $2.525B-$2.625B, consensus $2.6B
1M ago
EXEL
Exelixis (EXEL) Q4 Earnings Cheat Sheet
PremiumPre-EarningsExelixis (EXEL) Q4 Earnings Cheat Sheet
1M ago
EXEL
Exelixis price target raised to $44 from $41 at Barclays
Premium
The Fly
Exelixis price target raised to $44 from $41 at Barclays
1M ago
EXEL
Exelixis: Advancing Zanzalintinib Pipeline Underpins Buy Rating and $52 Target on Multi-Tumor Commercial Potential
Premium
Ratings
Exelixis: Advancing Zanzalintinib Pipeline Underpins Buy Rating and $52 Target on Multi-Tumor Commercial Potential
1M ago
EXEL
Exelixis reports zanzalintinib new drug application accepted for review by FDA
PremiumThe Fly
Exelixis reports zanzalintinib new drug application accepted for review by FDA
1M ago
EXEL
Exelixis price target raised to $49 from $48 at Morgan Stanley
PremiumThe Fly
Exelixis price target raised to $49 from $48 at Morgan Stanley
1M ago
EXEL
Exelixis price target raised to $52 from $49 at H.C. Wainwright
PremiumThe Fly
Exelixis price target raised to $52 from $49 at H.C. Wainwright
2M ago
EXEL
Exelixis price target raised to $51 from $49 at Truist
PremiumThe Fly
Exelixis price target raised to $51 from $49 at Truist
2M ago
EXEL
Exelixis reports preliminary FY25 revenue $2.32B, consensus $2.33B
PremiumThe FlyExelixis reports preliminary FY25 revenue $2.32B, consensus $2.33B
2M ago
EXEL
Exelixis sees FY26 revenue $2.525B-$2.625B, consensus $2.62B
Premium
The Fly
Exelixis sees FY26 revenue $2.525B-$2.625B, consensus $2.62B
2M ago
EXEL
Exelixis price target raised to $52 from $49 at H.C. Wainwright
Premium
The Fly
Exelixis price target raised to $52 from $49 at H.C. Wainwright
2M ago
EXEL

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >